Biologics

SpineOvations initiated a pilot clinical study of DiscSeal in patients suffering from lumbar spine pain after recently receiving Australian regulatory approval.

The American Academy of Orthopaedic Surgeons is investing in research and development for biologics in a five-year initiative announced on Nov. 20.

The FDA approved Cerapedics premarket approval supplement for i-Factor in anterior cervical discectomy and fusion procedures in patients with degenerative disc disease.

Alok Sharan, MD, was recently appointed to the scientific advisory board at NanoFUSE Biologics.

Boston Sports and Shoulder Center installed the Sonimage HS1 compact ultrasound system and the Sonimage MX1 portable ultrasound system at its five practices in the Boston metropolitan area.

Beacon Orthopaedics & Sports Medicine in Sharonville, Ohio, is providing Regenexx regenerative medicine treatments as an alternative to orthopedic surgery, reports WCPO.

California voters are wrestling with the question of whether to support a ballot initiative that will grant the Oakland-based California Institute for Regenerative Medicine another $5.5 billion to continue its research-funding efforts, the Sacramento Business Journal reports.

Sarasota, Fla.-based Bennett Orthopedics and Sportsmedicine is providing patients access to stem cell treatments to address pain.

Researchers at Troy, N.Y.-based Rensselaer Polytechnic Institute designed a biomaterial that could provide targeted treatment to injured spinal cords and tissue to prevent additional damage, reports Sci Tech Daily.

Seven former Osteo Relief Institutes and their owners will pay millions of dollars to settle fraud allegations.